Physicians for Reproductive Health Urges Supreme Court to Reverse Fifth Circuit Ruling on Medication Abortion
Press releases | January 30, 2024
On Tuesday, January 30, Fried Frank filed an amicus brief in the US Supreme Court on behalf of Physicians for Reproductive Health (PRH), a physician-led national advocacy organization that organizes, mobilizes and amplifies the voices of doctors to advance sexual and reproductive health, rights and justice. The brief urges the Supreme Court to reverse the ruling of the US Court of Appeals for the Fifth Circuit and to uphold US Food and Drug Administration (FDA) approvals with respect to the dispensing and conditions of use of mifepristone, a prescription drug routinely used in reproductive health care.
The PRH brief emphasizes the safety and efficacy of mifepristone as a course of treatment for both medication abortion and miscarriage management, as demonstrated by medical studies and the personal experiences of physicians in the PRH network. The brief argues that restricting access to mifepristone will limit patient options, harm patient health, impede patient autonomy and interfere with doctors’ ethical obligations. In particular, the brief sheds light on the use of mifepristone to induce labor and reduce the likelihood of adverse medical complications for patients experiencing pregnancy loss in the second and third trimesters. The brief also highlights that “[f]or Black people, Indigenous people, people of color, LGBTQ+ people, and people who are immigrants, removing an option that allows for increased privacy and independence while managing an abortion or miscarriage will exacerbate existing distrust in the medical system.”
The brief states: “The Fifth Circuit’s ruling, which purports to flip a switch and send the provision of care back to 2015, is likely to cause (and add to preexisting) mass confusion about what is lawful to prescribe and how to prescribe it – all of which will exacerbate the already existing harms outlined herein… In the weeks or months it will take patients and prescribers to sort out the regulatory nightmare that the Fifth Circuit’s Opinion seeks to restore, patients will struggle with access to care, and for some patients, certain treatment options will be foreclosed altogether.”
The full brief is available here. The Supreme Court will hear oral arguments about access to mifepristone on March 26.
The Fried Frank pro bono team that prepared the brief included partner Janice Mac Avoy, special counsel Laura Israel Sinrod, and associates Anne Aufhauser, Dylan B. Bolduc, Alexis Casamassima and Lucretia Bunzel.
Fried Frank prepared the brief, as well as the affiliated amicus brief in the US Supreme Court, which called for emergency relief, and amicus brief in the Fifth Circuit, in partnership with the Center for Reproductive Rights, a global legal advocacy organization that seeks to advance reproductive rights, including abortion.
This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm’s data policy page for further information.